CION Ameerpet
Choosing where to be treated is one of the most important decisions after a lymphoma diagnosis. This practical guide sets out the lymphoma centre criteria that genuinely matter — from accurate diagnosis to an experienced team, in-house therapy and transparent costs.
After a lymphoma diagnosis, where you are treated shapes almost everything that follows — how accurately your subtype is identified, how well your plan is built, and how supported you feel through months of treatment. Lymphoma is not one disease but a family of more than 60 subtypes, so the quality of the centre you choose has a real, measurable effect on your journey.
The good news is that the criteria for a good centre are knowable, and you can assess them before you commit. This page breaks the decision down into the signals that genuinely matter — accurate diagnosis, an experienced haematologist-led team, the ability to deliver core treatment directly, honest costs, and a willingness to give a second opinion. It is the same framework we use to describe our own service on the Best Lymphoma Hospital in Hyderabad page.
If you are weighing up options in Hyderabad, our team is happy to talk it through — including a free review of your biopsy and scans. You can book a free consultation at any point.
Lymphoma has more than 60 recognised subtypes, and the right treatment depends entirely on identifying the correct one. Both NCCN and ESMO guidelines state that an adequate biopsy reviewed by an experienced haemato-pathologist — with immunohistochemistry and, where needed, molecular testing — is the foundation of every lymphoma treatment plan. This is why a centre's diagnostic strength is one of the most important criteria to check. (Source: NCCN and ESMO Clinical Practice Guidelines for Hodgkin and non-Hodgkin lymphoma.)
Use these criteria as a checklist when you compare hospitals. Each one is a genuine quality signal — and each is something you can ask about directly.
| Criterion | Why it matters | What good looks like |
|---|---|---|
| Accurate diagnosis | The subtype decides the whole plan | Expert haemato-pathology, immunohistochemistry & molecular markers; re-reviews outside slides |
| Experienced team | Outcomes track with getting the plan right first time | Haematologist / medical oncologist who treats lymphoma regularly, plus radiation, radiology & nursing |
| Multidisciplinary board | Avoids blind spots, keeps to guidelines | A tumour board that reviews cases together against NCCN & ESMO standards |
| In-house therapy | Joined-up care, fewer hand-offs | Chemotherapy, immunotherapy & radiation on site; transplant & CAR-T coordinated with partners |
| Cost transparency | Treatment runs over months | Written estimates up front; insurance, cashless & scheme support explained |
| Second-opinion openness | Confidence in the plan; your right | Welcomes a second opinion without pressure |
This checklist is a general guide to help you compare centres; individual needs vary. The clinical standards referenced follow NCCN and ESMO lymphoma guidance.
A closer look at what separates a strong lymphoma centre — and how CION approaches each one.
Everything starts with the biopsy. A good centre reviews it with experienced haemato-pathology and orders the immunohistochemistry and molecular markers — CD20, CD30, MYC, BCL2, cell-of-origin — that pin down your exact subtype. Rushed or incomplete diagnosis is the most common reason plans go wrong.
Ask who leads your care. A haematologist or medical oncologist who treats lymphoma regularly, backed by radiation oncology, radiology and specialist nursing, is a strong signal. Meet the lymphoma doctors before you decide.
The core of lymphoma treatment — chemotherapy, antibody immunotherapy and radiation — should be available on site so your care stays joined up. Specialised options such as stem cell transplant and CAR T-cell therapy are coordinated through accredited partner facilities.
A good centre gives a written estimate up front and explains what drives it — the subtype, the treatment plan, scans and any immunotherapy. It helps you use cashless insurance and eligible government schemes.
We're never more than 30 minutes away. Same panel of specialists at every centre. Same tumour board reviews. Same NCCN protocols. Pick the closest one and call directly — or let us pick for you.
CION Ameerpet
CION Kukatpally
CION L.B. Nagar
CION Tolichowki
CION Masab Tank
CION Banjara Hills
CION Kompally
CION Balanagar
CION Siddipet
CION Sangareddy
Not sure which centre fits best? Tell us where you are — we'll suggest the closest one with the right specialists.
Help me pick the right centreTravelling for treatment? We may have a centre right where you are.
Don't see your city? Call 18002028726 — we'll find your nearest CION partner centre.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationShare your name and number — we'll call you back within 30 minutes to schedule your consultation.
Bring your questions and your reports. CION's haematologist-led team will explain your subtype, your options and your costs clearly — and give you a free written second opinion before you commit.
If there is one thing to check above all others, it is how a centre diagnoses lymphoma. Because treatment differs sharply between subtypes, an accurate classification is what makes the rest of the plan meaningful. NCCN and ESMO both place an adequate, expertly reviewed biopsy at the centre of every pathway.
A strong centre reviews your biopsy with a pathologist experienced specifically in blood cancers, and is willing to re-review slides brought from elsewhere. Immunohistochemistry and molecular markers — CD20, CD30, MYC, BCL2 and cell-of-origin testing — are used to confirm the exact subtype. These markers are testing concepts, not treatments, and they directly shape what comes next.
Once the subtype is known, staging shows how far the lymphoma has spread. This usually involves a PET-CT scan and, where indicated, a bone-marrow examination. A good centre performs and interprets these directly, so staging and planning stay under one team rather than scattered across providers.
The findings should then be reviewed by a multidisciplinary tumour board — haematology, radiation oncology, radiology, pathology and nursing in one room. This is where the plan is set against current lymphoma treatment standards, and it is one of the clearest markers of a centre that takes accuracy seriously.
Survival in lymphoma varies widely by subtype — which is exactly why an accurate diagnosis and a well-chosen centre matter. Across published series, classical Hodgkin lymphoma has a five-year survival of roughly 80–90%, and diffuse large B-cell lymphoma (the commonest aggressive non-Hodgkin type) around 60–70% with modern treatment. These are population figures — individual outcomes vary by stage, age, subtype and response. (Source: published survival series referenced in NCCN and ESMO lymphoma guidelines; figures vary by individual.)
An honest centre is clear about which treatments it provides itself and which it refers to accredited partners. That transparency is a quality signal in its own right. Here is how care is organised at CION:
Chemotherapy, antibody-based immunotherapy, targeted therapy, precision radiation (IMRT), biopsy, bone-marrow examination, watch-and-wait monitoring, tumour board review and long-term survivorship care are all delivered in-house. Keeping these under one team means fewer hand-offs and a plan that stays joined up from diagnosis through follow-up. Note that specific drug regimens are individualised — our team explains yours on the Lymphoma Treatment page and in consultation.
The most complex treatments — stem cell transplant and CAR T-cell therapy — are coordinated through accredited partner facilities with dedicated transplant units. A good centre manages these referrals so nothing falls between the cracks, and stays involved in your care throughout.
Because treatment spans months, a good centre helps you plan financially. That means a written estimate covering the chemotherapy plan and scans, help with cashless insurance, and guidance on schemes such as Aarogyasri (Telangana) or NTR Vaidya Seva (Andhra Pradesh) if you qualify.
A handful of focused questions will tell you most of what you need to know about a lymphoma centre:
A centre that answers these openly is one that plans around your healing, not your bill. If you would like a considered, independent view, CION offers a dedicated free written second-opinion service — read more on our getting a second opinion for lymphoma page, request one here, or call 18002028726.
Get a free written second opinion from CION's haematologist-led tumour board — and see for yourself how we meet each of the criteria on this page.
These aren't paid endorsements or written reviews. These are video testimonials from real patients and families — recorded on their own phones, in their own words. Pick any one. Watch it. Then decide.
Read all 800+ reviews on Google
Start Your Story. Book Free Consultation.A good lymphoma centre brings the whole pathway together under one roof — accurate diagnosis, a multidisciplinary tumour board, and the ability to deliver chemotherapy, immunotherapy and radiation directly. Look for expert haemato-pathology and molecular testing (markers such as CD20, CD30, MYC and BCL2, and cell-of-origin), a haematologist-led team, and clear, written treatment plans. It should coordinate advanced options such as stem cell transplant and CAR T-cell therapy through accredited partner facilities when needed. Just as important are transparent costs, insurance and cashless support, and a genuine willingness to give a second opinion. These are the core criteria we describe throughout this page.
Start with the diagnosis: ask whether the hospital reviews your biopsy with expert haemato-pathology and orders the immunohistochemistry and molecular markers that define your exact subtype. Then check that a haematologist or medical oncologist leads care, that a multidisciplinary team meets to plan it, and that chemotherapy, antibody (immunotherapy) and radiation are available on site. Ask how they coordinate transplant or CAR T-cell therapy if you ever need it. Finally, weigh the practical criteria — transparent costs, insurance and cashless support, location and follow-up. Our Best Lymphoma Hospital in Hyderabad page walks through how CION meets each of these.
Lymphoma has more than 60 recognised subtypes, and the right treatment depends entirely on getting that classification correct. According to NCCN and ESMO guidance, an adequate biopsy reviewed by an experienced haemato-pathologist — with immunohistochemistry and, where needed, molecular testing — is the foundation of every plan. A centre that rushes or skips this step can set off down the wrong path. This is why one of the most important lymphoma centre criteria is a strong diagnostic engine: expert pathology, markers such as CD20 and CD30, and a willingness to re-review outside slides. If your diagnosis is unclear, a second opinion before treatment is well worth it.
The best model is a centre that delivers the core of lymphoma care directly and coordinates the specialised parts through accredited partners. At CION, chemotherapy, antibody-based immunotherapy, targeted therapy, radiation (IMRT), biopsy, bone-marrow examination, watch-and-wait monitoring, tumour board review and survivorship care are all delivered in-house. The most complex treatments — stem cell transplant and CAR T-cell therapy — are coordinated through accredited partner facilities, because they require dedicated transplant units. A good centre is honest about what it does itself and what it refers, and manages the hand-offs so your care stays joined up.
Very. Lymphoma treatment runs over months, so unclear billing adds real stress on top of illness. A good centre gives you a written estimate before you start and explains what drives the cost — the subtype, the chemotherapy plan, scans such as PET-CT, and any immunotherapy. Ask about cashless insurance, and, if you are eligible, government schemes such as Aarogyasri in Telangana or NTR Vaidya Seva in Andhra Pradesh. Cost transparency is a genuine quality signal — it reflects a centre that plans around your healing, not your bill.
Yes. Outcomes in lymphoma are strongly linked to getting the plan right the first time, and that depends on the people making it. Look for a haematologist or medical oncologist who treats lymphoma regularly, supported by radiation oncology, pathology, radiology and nursing. A multidisciplinary tumour board — where these specialists review your case together — helps avoid blind spots and keeps the plan aligned with NCCN and ESMO standards. Meet the lymphoma doctors before you commit, and ask how often the board meets. A collaborative, experienced team is one of the clearest markers of a good lymphoma treatment centre.
A few focused questions reveal a lot. Ask: Who will review my biopsy, and will you order the markers that confirm my exact subtype? Which parts of treatment do you deliver here, and what do you refer to a partner? How is my plan decided — is there a tumour board? Can I have a written cost estimate and see whether cashless insurance or a government scheme applies? Will you support a second opinion without pressure? Who manages side effects and follow-up? Honest, specific answers point to a centre confident in its care. You can raise all of these when you book a free consultation with our team.
Browse our complete guide to lymphoma — symptoms, diagnosis, Hodgkin and non-Hodgkin subtypes, treatment, genetics, prognosis, survivorship and cost. Tap any topic to read more.